We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

158 hedge funds and large institutions have $3.61B invested in Loxo Oncology, Inc in 2018 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 48 increasing their positions, 55 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 15

32% more capital invested

Capital invested by funds: $2.74B → $3.61B (+$875M)

12% more funds holding

Funds holding: 141158 (+17)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

13% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 55

52% less call options, than puts

Call options by funds: $16.8M | Put options by funds: $34.9M

Holders
158
Holders Change
+17
Holders Change %
+12.06%
% of All Funds
3.62%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.14%
New
36
Increased
48
Reduced
55
Closed
15
Calls
$16.8M
Puts
$34.9M
Net Calls
-$18M
Net Calls Change
-$18.2M
Name Holding Trade Value Shares
Change
Change in
Stake
TCIM
51
TIAA CREF Investment Management
New York
$7.84M -$33.2K -312 -0.5%
QIM
52
Quantitative Investment Management
Virginia
$6.91M +$4.86M +45,700 +322%
USAA
53
United Services Automobile Association
Texas
$6.82M -$860K -8,084 -12%
JP Morgan Chase
54
JP Morgan Chase
New York
$6.62M -$857K -8,058 -12%
GH
55
GAM Holding
Switzerland
$5.68M -$681K -6,400 -12%
California Public Employees Retirement System
56
California Public Employees Retirement System
California
$5.44M -$353K -3,316 -7%
TA
57
Teachers Advisors
New York
$4.88M +$72.2K +679 +2%
AA
58
ALPS Advisors
Colorado
$4.62M +$740K +6,959 +21%
TD Asset Management
59
TD Asset Management
Ontario, Canada
$4.32M +$862K +8,100 +28%
Swiss National Bank
60
Swiss National Bank
Switzerland
$4.2M +$74.5K +700 +2%
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$4.02M -$130K -1,221 -3%
Federated Hermes
62
Federated Hermes
Pennsylvania
$3.58M +$3.3M +31,031 New
GC
63
Guggenheim Capital
Illinois
$3.4M -$571K -5,367 -15%
UBS Group
64
UBS Group
Switzerland
$3.23M +$1.63M +15,308 +120%
EI
65
EAM Investors
California
$2.87M +$2.64M +24,865 New
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
$2.85M +$42.5K +400 +2%
PPA
67
Parametric Portfolio Associates
Washington
$2.71M +$993K +9,335 +66%
State of Wisconsin Investment Board
68
State of Wisconsin Investment Board
Wisconsin
$2.58M
American Century Companies
69
American Century Companies
Missouri
$2.57M +$2.37M +22,314 New
ACM
70
Atika Capital Management
New York
$2.48M +$2.29M +21,500 New
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
$2.46M -$75.3K -708 -3%
AQR Capital Management
72
AQR Capital Management
Connecticut
$2.03M -$657K -6,174 -26%
SGH
73
Sivik Global Healthcare
Connecticut
$2.02M
CIA
74
Capital Impact Advisors
Massachusetts
$1.99M +$1.84M +17,271 New
Manulife (Manufacturers Life Insurance)
75
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.97M -$53.2K -500 -3%

LOXO Hedge Fund Activity: Q1 2018 in Review

158 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q1 2018, worth a combined $3.61B — up 32% from $2.74B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new LOXO positions and 15 closed out — a net gain of 21 holders — while 48 added to existing stakes and 55 trimmed.

The largest buyer was Boxer Capital, opening a new position worth an estimated $42.5M. The largest seller was OrbiMed, cutting an estimated $9.91B.

  • 158 institutional investors held Loxo Oncology, Inc (LOXO) as of Q1 2018, up from 141 in Q4 2017.
  • Funds reported $3.61B of Loxo Oncology, Inc stock for Q1 2018, up 32% quarter-over-quarter.
  • 36 funds opened new Loxo Oncology, Inc positions in Q1 2018 and 15 closed out, a net change of +21 holders.
  • The largest Loxo Oncology, Inc buyer in Q1 2018 was Boxer Capital, an estimated $42.5M added.
  • The largest Loxo Oncology, Inc seller in Q1 2018 was OrbiMed, an estimated $9.91B sold.

Based on aggregated 13F filings for Q1 2018.